Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2013 | 11 | 1 | 63-77

Article title

QSAR study and molecular docking on indirubin inhibitors of Glycogen Synthase Kinase-3


Title variants

Languages of publication



The current study describes the development of in silico models based on a novel alternative of the MTD-PLS methodology (Partial-Least-Squares variant of Minimal Topologic Difference) developed by our group to predict the inhibition of GSK-3β by indirubin derivatives. The new MTD-PLS methodology involves selection rules for the PLS equation coefficients based on physico-chemical considerations aimed at reducing the bias in the output information. These QSAR models have been derived using calculated fragmental descriptors relevant to binding including polarizability, hydrophobicity, hydrogen bond donor, hydrogen bond acceptor, volume and electronic effects. The MTD-PLS methodology afforded moderate but robust statistical characteristics (R2
Y(CUM) = 0.707, Q2(CUM) = 0.664). The MTD-PLS model obtained has been validated in terms of predictive ability by joined internal-external cross-validation applying Golbraikh-Tropsha criteria and Y-randomization test. The information supplied by the MTD-PLS model has been evaluated against Fujita-Ban outcomes that afforded a statistically reliable model (R2=0.923). Furthermore, the results originated from QSAR models were laterally validated with docking insights that suggested the substitution pattern for the design of new indirubins with improved pharmacological potential against GSK-3β. The new restriction rules introduced in this paper are applicable and provide reliable results in accordance with physico-chemical reality.










Physical description


1 - 1 - 2013
24 - 10 - 2012


  • Institute of Chemistry of the Romanian Academy
  • Institute of Chemistry of the Romanian Academy
  • Institute of Chemistry of the Romanian Academy
  • Institute of Chemistry of the Romanian Academy
  • University of Medicine and Pharmacy “Victor Babes”
  • Institute of Chemistry of the Romanian Academy


  • [1] N. Embi, D.B. Rylatt, P. Cohen, Eur. J. Biochem. 107, 519 (1980) http://dx.doi.org/10.1111/j.1432-1033.1980.tb06059.x[Crossref]
  • [2] A. Vulpetti, P. Crivori, A. Cameron, J. Bertrand, M.G. Brasca, R. D’Alessio, P. Pevarello, J. Chem. Inf. Model. 45, 1282 (2005) http://dx.doi.org/10.1021/ci0500280[Crossref]
  • [3] A. Ali, K.P. Hoeflich, J.R. Woodgett, Chem. Rev. 101, 2527 (2001) http://dx.doi.org/10.1021/cr000110o[Crossref]
  • [4] H.C. Zhang, H. Ye, B.R. Conway, C.K. Derian, M.F. Addo, G.H. Kuo, L.R. Hecker, D.R. Croll, J. Li, L. Westover, J.Z. Xu, R. Look, K.T. Demarest, P. Andrade-Gordon, B.P. Damiano, B.E. Maryanoff, Bioor. Med. Chem. Lett. 14, 3245 (2004) http://dx.doi.org/10.1016/j.bmcl.2004.03.090[Crossref]
  • [5] J.A. Bertrand, S. Thieffine, A. Vulpetti, C. Cristiani, B. Valsasina, S. Knapp, H.M. Kalisz, M. Flocco, J. Mol. Biol. 333, 393 (2003) http://dx.doi.org/10.1016/j.jmb.2003.08.031[Crossref]
  • [6] Y. Mettey, M. Gompel, V. Thomas, M. Garnier, M. Leost, I. Ceballos-Picot, M. Noble, J. Endicott, J.M. Vierfond, L. Meijer, J. Med. Chem. 46, 222 (2003) http://dx.doi.org/10.1021/jm020319p[Crossref]
  • [7] Y. Wan, W. Hur, C.Y. Cho, Y. Liu, F.J. Adrian, O. Lozach, S. Bach, T. Mayer, D. Fabbro, L. Meijer, N.S. Gray, Chem.Biol. 11, 247 (2004)
  • [8] E. Lescot, R. Bureau, J. Sopkova-de Oliveira Santos, C. Rochais, V. Lisowski, J.C. Lancelot, S. Rault, J. Chem. Inf. Model. 45, 708 (2005) http://dx.doi.org/10.1021/ci050008y[Crossref]
  • [9] E.J. Henriksen, T.R. Kinnick, M.K. Teachey, M.P. O_Keefe, D. Ring, K.W. Johnson, S.D. Harrison, Am. J. Physiol. Endocrinol. Metab. 284, E892 (2003)
  • [10] Z. Xiao, Y. Hao, B. Liu, L. Qian, Leuk. Lymphoma 43, 1763 (2002) http://dx.doi.org/10.1080/1042819021000006295[Crossref]
  • [11] Z.H. Wang, Y. Dong, T. Wang, M.H. Shang, W.Y. Hua, Q.Z. Yao, Chin. Chem. Lett. 21, 297 (2010) http://dx.doi.org/10.1016/j.cclet.2009.11.029[Crossref]
  • [12] S. Leclerc, M. Garnier, R Hoessel, D. Marko, J.A. Bibb, G.L. Snyder, P. Greengard, J. Biernat, Y.Z. Wu, E.M. Mandelkow, G. Eisenbrand, L. Meijer, J. Biol. Chem. 276, 251 (2001) http://dx.doi.org/10.1074/jbc.M002466200[Crossref]
  • [13] A. Martinez, A. Castro, I. Dorronsoro, M. Alonso, Med. Res. Rev. 22, 373 (2002) http://dx.doi.org/10.1002/med.10011[Crossref]
  • [14] P. Polychronopoulos, P. Magiatis, A.L. Skaltsounis, V. Myrianthopoulos, E. Mikros, A. Tarricone, A. Musacchio, S.M. Roe, L. Pearl, M. Leost, P. Greengard, L. Meijer, Med. Chem. 47, 935 (2004) http://dx.doi.org/10.1021/jm031016d[Crossref]
  • [15] A. Beauchard, Y. Ferandin, S. Frère, O. Lozach, M. Blairvacq, L. Meijer, V. Thièry, T. Besson, Bioorg. Med. Chem. 14, 6434 (2006) http://dx.doi.org/10.1016/j.bmc.2006.05.036[Crossref]
  • [16] Y. Ferandin, K. Bettayeb, M. Kritsanida, O. Lozach, P. Polychronopoulos, P. Magiatis, A.L. Skaltsounis, L. Meijer, J. Med. Chem. 49, 4638 (2006) http://dx.doi.org/10.1021/jm060314i[Crossref]
  • [17] K. Vougogiannopoulou, Y. Ferandin, K. Bettayeb, V. Myrianthopoulos, O. Lozach, Y. Fan, C.H. Johnson, P. Magiatis, A.L. Skaltsounis, E. Mikros, L. Meijer, J. Med. Chem. 51, 6421 (2008) http://dx.doi.org/10.1021/jm800648y[Crossref]
  • [18] L. Kurunczi, M. Olah, T.I. Oprea, C. Bologa, Z. Simon, J. Chem. Inf. Comput. Sci. 42, 841 (2002) http://dx.doi.org/10.1021/ci010124a[Crossref]
  • [19] L. Kurunczi, E. Seclaman, T.I. Oprea, L. Crisan, Z. Simon, J. Chem. Inf. Model. 45, 1275 (2005) http://dx.doi.org/10.1021/ci050077c[Crossref]
  • [20] Marvin version (ChemAxon, Budapest, Hungary, 2011)
  • [21] S.K. Dogra, A. Das, K. Subramanian, In: G. Cruciani (Ed.), The 233th ACS National Meeting, Chicago, IL, March 25–29, 2007, General Papers, Division of Chemical Information, http://www.qsarworld.com/files/ACS_3D_Descriptors_Conformers.pdf
  • [22] M. Pastor, Alignment-independent Descriptors from Molecular Interaction Fields, in Molecular Interaction Fields. Applications in Drug Discovery and ADME Prediction (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2006) 117–142 http://dx.doi.org/10.1002/3527607676.ch6[Crossref]
  • [23] T.I. Oprea, L. Kurunczi, M. Olah, Z. Simon, SAR QSAR EnViron. Res. 12, 75 (2001) http://dx.doi.org/10.1080/10629360108035372[Crossref]
  • [24] SIMCA P, version 9.0 (Umetrics AB, Umea, Sweden, 2001)
  • [25] M.H. Abraham, P.P. Duce, D.V. Prior, D.G. Barratt, G.G. Morris, P.J. Taylor, J. Chem. Soc. Perkin Trans. II. 1355 (1989)
  • [26] O.A. Raevsky, In: R. Mannhold (Ed.), H - bonding Parameterization in Quantitative Structure - Activity Relationships and Drug Design, in Molecular Drug Properties. Measurement and Prediction (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2008) 127–154
  • [27] O.A. Raevsky, V.Ju. Grigor’ev, D. Kireev, N.S. Zefirov, Quant. Struct. Act. Relat. 11, 49 (1992) http://dx.doi.org/10.1002/qsar.19920110109[Crossref]
  • [28] Hyperchem 7.52 release for Windows (HyperCube, Inc., Gainesville, Florida, USA, 2005) http://www.hyper.com
  • [29] F.C. Bernstein, T.F. Koetzle, G.J. Williams, E.E. Meyer Jr., M.D. Brice, J.R. Rodgers, O. Kennard, T. Shimanouchi, M. Tasumi, J. Mol. Biol. 112, 535 (1977) http://dx.doi.org/10.1016/S0022-2836(77)80200-3[Crossref]
  • [30] M. Olah, Rev Roum. Chim. 45, 1123 (2000)
  • [31] F. Lindgren, B. Hansen, W. Karcher, M. Sjöström, L. Eriksson, J. Chemom. 10, 521 (1996) http://dx.doi.org/10.1002/(SICI)1099-128X(199609)10:5/6<521::AID-CEM448>3.0.CO;2-J[Crossref]
  • [32] P.P. Roy, S. Paul, I. Mitra, K. Roy, Molecules 14, 1660 (2009) http://dx.doi.org/10.3390/molecules14051660[Crossref]
  • [33] A.R. Katritzky, S. Slavov, D. Dobchev, M. Karelson, Comp. Chem. Eng. 31, 1123 (2007) http://dx.doi.org/10.1016/j.compchemeng.2006.10.001[Crossref]
  • [34] A.R. Katritzky, L.M. Pacureanu, D. Dobchev, D.C. Fara, P.R. Duchowicz, M. Karelson, Bioorg. Med. Chem. 14, 4987 (2006) http://dx.doi.org/10.1016/j.bmc.2006.03.009[Crossref]
  • [35] A. Golbraikh, A. Tropsha, J. Comp. Aid. Mleol. Des. 16, 357 (2002) http://dx.doi.org/10.1023/A:1020869118689[Crossref]
  • [36] A. Golbraikh, A. Tropsha, J. Comp. Aid. Mol. Des. 120, 269 (2002)
  • [37] A. Golbraikh, M. Shen, Z. Xiao, K.H. Lee, A. Tropsha, J. Comp. Aid. Mol. Des. 17, 241 (2003) http://dx.doi.org/10.1023/A:1025386326946[Crossref]
  • [38] OpenEye Scientific Software (OpenEye Inc., Santa Fe, USA, 2009)
  • [39] L. Eriksson, E. Johansson, N. Kettaneh-Wold, S. Wold, Multi- and MegaVariate Data Analysis. Principles and Applications (Umetrics AB: Umeå, Sweden, 2001) 94–97
  • [40] N. Zhang, Y. Jiang, J. Zou, B. Zhang, H. Jin, Y. Wang, Q. Yu, Eur. J. Med. Chem. 41, 373 (2006) http://dx.doi.org/10.1016/j.ejmech.2005.10.018[Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.